In a recent move by Israel’s Ministry of Health, regulations surrounding medical cannabis prescriptions have been overhauled. Itai Rogel, head of business development for Bazelet Group, a medical cannabis producer in Or Akiva, Israel, believes that empowering medical professionals with greater flexibility will ultimately benefit the patients who rely on cannabis-derived therapies.Israeli Medical Cannabis Market Continues to Flourish Despite ChallengesWith the number of medical cannabis patients in Israel reaching an all-time high, experts project the value of the nation’s medical marijuana market to reach approximately $340 million. Some investors worry that increased security measures could impact imports, supply chains, and investments in Israel’s blooming medical cannabis sector.Paving the Way for a New Era in Medical Marijuana ConvictionThe relaxation of restrictions regarding medical cannabis prescriptions demonstrates Israel’s commitment to evolving its regulatory framework in response to the growing needs of patient populations. This change will potentially lead to broader access to cannabis treatments for patients, granting doctors more discretion in their prescription practices. By continuing on this visionary trajectory, Israel has cemented its place as a global influencer in the world of medical marijuana, benefitting patients and researchers alike.
In a recent move by Israel’s Ministry of Health, regulations surrounding medical cannabis prescriptions have been overhauled. The new changes, implemented in January, grant specialist doctors at public hospitals such as Sourasky Medical Center in Tel Aviv the authority to prescribe cannabis starting in March. These revisions aim to enhance physician autonomy, making it easier for them to approve medical cannabis use and improving access for patients who require the treatment.
Removing Obstacles and Expanding Treatment Scope
One significant aspect of the changes in the law...
Read the full article @ Marijuana Index